Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00060-8/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-_8uVCJ3RrrlQxboJLqAOocvo8ajafgVfHGjl77Z6StjOUPcvNDUeDVUkURePw-dviWl6-q27QKCsvPCq7MiQi68W-GFw&_hsmi=378867005&utm_content=378598878&utm_source=hs_email